Suriname vs Trinidad and Tobago: Prevalence of anemia among women of reproductive age
Suriname
22.2%
in 2023
Trinidad and Tobago
22.1%
in 2023
Suriname rank
123rd
Trinidad and Tobago rank
125th
Prevalence of anemia among women of reproductive age over time
- Suriname
- Trinidad and Tobago
How they compare
Suriname currently reports 22.2% against 22.1% in Trinidad and Tobago, a difference of 0.1%.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Suriname ahead.
Suriname ranks 123rd and Trinidad and Tobago ranks 125th of 192 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Suriname | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.7% | 22.9% | 0.8% | Suriname |
| 2010s | 19.5% | 19.1% | 0.4% | Suriname |
| 2020s | 21.3% | 21.2% | 0.0% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, Suriname or Trinidad and Tobago?
- Suriname, at 22.2% against 22.1% in Trinidad and Tobago as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between Suriname and Trinidad and Tobago?
- 0.1%, with Suriname ahead.
- How many years of comparable data are there for Suriname and Trinidad and Tobago?
- 24 years are reported by both, from 2000 to 2023.
- How do Suriname and Trinidad and Tobago rank globally for prevalence of anemia among women of reproductive age?
- Suriname ranks 123rd and Trinidad and Tobago ranks 125th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.